Effect of dynamic culture conditions on the production of an erythroid progenitor cell line within fluidised bed bioreactors

IF 3.7 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
David Phillips , Marianne J. Ellis , Jan Frayne , Sandhya Moise
{"title":"Effect of dynamic culture conditions on the production of an erythroid progenitor cell line within fluidised bed bioreactors","authors":"David Phillips ,&nbsp;Marianne J. Ellis ,&nbsp;Jan Frayne ,&nbsp;Sandhya Moise","doi":"10.1016/j.bej.2025.109936","DOIUrl":null,"url":null,"abstract":"<div><div>Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/mL) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"225 ","pages":"Article 109936"},"PeriodicalIF":3.7000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25003109","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Red blood cells (RBCs) are an essential therapeutic resource; however, insufficient supply and risks of blood-borne infections drive the need for alternative sources. The Bristol Erythroid Lineage – Adult (BEL-A) erythroid progenitor cell line provides a new source for the indefinite production of cultured RBCs, but efficient and scalable bioprocessing strategies are yet to be established. Fluidised bed bioreactors (FBBs), with their low-shear environments and high mass transfer capabilities, can support high-density cultures, particularly at large scales, offering a promising manufacturing platform for BEL-A expansion. However, their optimal operating conditions and effects on BEL-A cell have yet to be defined. Using a design of experiments statistical approach, we systematically investigated how dynamic culture conditions impact BEL-A proliferation within FBBs. A lower media perfusion velocity, reduced initial cell seeding number, and a higher cell density (cells/mL) enhanced cellular proliferation. We demonstrate that FBB culture achieved productivity comparable to static culture whilst offering scalability and reduced manual handling. Importantly, no spontaneous differentiation of BEL-A cells was observed, confirming the system’s suitability for maintaining progenitor cell characteristics. This study is the first to demonstrate the feasibility of FBBs for mammalian single-cell suspension culture, using BEL-A as a model system. Furthermore, our work represents a critical step towards the clinical-scale manufacture of BEL-A cells and unlocking their therapeutic potential as a source of cultured RBCs.
动态培养条件对流化床生物反应器内红系祖细胞系产生的影响
红细胞(rbc)是必不可少的治疗资源;然而,供应不足和血源性感染的风险促使需要寻找替代来源。布里斯托尔红系-成体(BEL-A)红系祖细胞系为培养红细胞的无限生产提供了新的来源,但有效和可扩展的生物处理策略尚未建立。流化床生物反应器(FBBs)具有低剪切环境和高传质能力,可以支持高密度培养,特别是在大规模培养时,为BEL-A扩展提供了一个有前途的制造平台。然而,它们的最佳操作条件和对BEL-A细胞的影响尚未确定。使用实验设计统计方法,我们系统地研究了动态培养条件如何影响fb内BEL-A的增殖。较低的介质灌注速度、较低的初始细胞播种数和较高的细胞密度(细胞/mL)可促进细胞增殖。我们证明了FBB文化在提供可伸缩性和减少人工处理的同时实现了与静态文化相当的生产力。重要的是,没有观察到BEL-A细胞的自发分化,证实了该系统对维持祖细胞特征的适用性。本研究首次以BEL-A为模型系统,证明了FBBs用于哺乳动物单细胞悬浮培养的可行性。此外,我们的工作代表了临床规模制造BEL-A细胞和释放其作为培养红细胞来源的治疗潜力的关键一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biochemical Engineering Journal
Biochemical Engineering Journal 工程技术-工程:化工
CiteScore
7.10
自引率
5.10%
发文量
380
审稿时长
34 days
期刊介绍: The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology. The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields: Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells Bioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信